Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 2, 1998, Pages 111-120

  Shankar, Premlata ^a   Sprang, Heidi ^a   Lieberman, Judy ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

A2 restricted reverse transcriptase epitope; CD4 T cell lysis; Cytotoxic T lymphocyte

Indexed keywords

CD4 ANTIGEN; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING;

AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; EPITOPE MAPPING; EPITOPES; FLOW CYTOMETRY; HIV SEROPOSITIVITY; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MICROSPHERES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031655428     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199810010-00002     Document Type: Article

References (29)

1. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-10.
2. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency type I syndrome. J Virol 1994;68:4650-5.
3. McMichael AJ, Walker BD. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 1994;8(Suppl 1):155-73.
4. DiBrino M, Parker KC, Shiloach J, et al. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci USA 1993;90:1508-12.
5. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-6.
6. Hunt DF, Henderson RA, Shabanowitz J, et al. Characterization of peptides bound to class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992;255:1261-3.
7. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993;74:929-37.
8. Dupuis M, Kundu SK, Merrigan TC. Characterization of HLA-A* 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein. J Immunol 1995;155:2232-9.
9. Sette A, Vitiello A, Reherman B, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994;153:5586-92.
10. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for haplotype and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford, UK: Oxford University Press, 1992:1065-1220.
11. Hadida F, Haas G, Zimmermann N, et al. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 nef. J Immunol 1995;154:4174-85.
12. Johnson RP, Trocha A, Yang L, et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. J Immunol 1991;147:1512-21.
13. Shankar P, Fabry JA, Fong DM, Lieberman J. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. Immunol Lett 1996;52:23-30.
14. Walker BD, Flexner C, Birch LK. Long-term culture and fine specificity of human cytotoxic T lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1989;86:9514-18.
15. Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med 1994;180:1283-93.
16. Yang OO, Kalams SA, Rosenzweig M, et al. Efficient lysis of Human Immunodeficiency Virus type 1-infected cells by cytotoxic T lymphocytes. J Virol 1996;70:5799-806.
17. Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in TxB lymphoblast hybrids. Immunogenetics 1985;21:235-46.
18. Chen BK, Gandhi RT, Baltimore D. CD4 Down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env and nef. J Virol 1996;70:6044-53.
19. Lieberman J, Fabry J, Fong, DM, Parkerson GR. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocyte response to HIV type 1 in an infected individual. AIDS Res Hum Retroviruses 1997;13:383-92.
20. Lieberman J, Fabry J, Shankar P, Beckett L, Skolnik PR. Ex vivo expansion of HIV-1 specific cytotoxic T cells from HIV-1 sero-positive subjects. AIDS Res Human Retroviruses 1995;11:257-71.
21. Ratner L, Haseltine W, Patarc R, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985;313:277-84.
22. Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986;5:943-9.
23. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987;326:881-2.
24. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177:249-56.
25. Harrer E, Harrer T, Barbosa P, et al. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J Infect Dis 1996;173:476-9.
26. Sykulev Y, Brunmark A, Tsomides TJ, et al. High-affinity reactions between antigen-specific T cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Sci USA 1992;91:11487-91.
27. Ferrari G, Humphrey W, McElrath MJ, et al. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Sci USA 1997;94:1396-401.
28. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility class I molecules is induced by the HIV-Nef protein. Nat Med 1996;2:338-42.
29. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 NEF protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.